Ultragenyx Pharmaceutical
RARE
#5300
Rank
C$2.33 B
Marketcap
C$22.96
Share price
-1.17%
Change (1 day)
-49.69%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): C-$7.25

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is C-$7.41. In 2025 the company made an earnings per share (EPS) of C-$8.34 an increase over its 2024 EPS that were of C-$9.05.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$7.25-12.99%
2025C-$8.34-7.89%
2024C-$9.05-23.89%
2023C-$11.89-17.61%
2022C-$14.4350.67%
2021C-$9.58113.69%
2020C-$4.48-55.9%
2019C-$10.1782.56%
2018C-$5.57-45.15%
2017C-$10.1514.68%
2016C-$8.85
2014C-$3.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
C-$0.20-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02855-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA